Literature DB >> 33950153

Treatment of Severe Multicentric Reticulohistiocytosis With Upadacitinib.

Omid Zahedi Niaki1, Erin Penn2, Deborah A Scott3, Gabriela Cobos3, Ruth Ann Vleugels3, Michael E Weinblatt4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33950153     DOI： 10.1001/jamadermatol.2021.0996

Source DB:  PubMed          Journal:  JAMA Dermatol        ISSN： 2168-6068            Impact factor:   10.282


× No keyword cloud information.
  2 in total

1.  Clinical characteristics of multicentric reticulohistiocytosis and distinguished features from rheumatoid arthritis: a single-center experience in China.

Authors:  Xiao-Juan Zou; Lin Qiao; Feng Li; Hua Chen; Yun-Jiao Yang; Dong Xu; Wen-Jie Zheng; Zhen-Yu Jiang; Li Wang; Qing-Jun Wu; Feng-Chun Zhang
Journal:  Orphanet J Rare Dis       Date:  2022-04-12       Impact factor: 4.123

2.  Case Report: Multicentric Reticulohistiocytosis Associated With Posterior Mediastinal Adenosquamous Carcinoma, Antinuclear Antibody Positivity and Lupus Anticoagulant Positivity.

Authors:  Ziyi Tang; Xiangpeng Wang; Zijing Xia; Zhongming Wang; Yi Zhao; Yi Liu
Journal:  Front Immunol       Date:  2022-01-07       Impact factor: 7.561
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.